Keyphrases
Hepatitis B Virus
67%
Hepatitis B Surface Antigen (HBsAg)
29%
Chronic Hepatitis B
27%
Chronic Hepatitis B Patients
25%
Interferon-α (IFN-α)
24%
Covalently Closed Circular DNA
20%
In Situ Hybridization
19%
Hepatitis B Virus RNA
19%
Circulating Tumor DNA (ctDNA)
15%
MicroRNA
15%
Virus
14%
Hepatitis B Virus Replication
13%
Hepatitis B Virus DNA
13%
Capsid
12%
Pregenomic RNA (pgRNA)
12%
Recombinant
12%
COVID-19
11%
Quantitative PCR
10%
Chronic Hepatitis B Virus Infection
9%
Gene Expression
9%
H7N9 Virus
8%
Liver Fibrosis
8%
RNA-DNA
8%
Mouse Model
8%
Antigen-antibody Complex
8%
Enterovirus 71 (EV71)
8%
Hepatitis B Virus Infection
8%
H7N9 Influenza Virus
7%
Hepatitis C Virus
7%
In Situ Assay
7%
Fluorescence in Situ Hybridization
7%
HepAD38
7%
Virion
7%
Severe Cases
7%
Pathobiology
7%
Sustained Virological Response
7%
Enterovirus 71 Infection
6%
Rupintrivir
6%
Virus Polymerase
6%
MicroRNA Profile
6%
Myeloid Differentiation Factor 88 (MyD88)
6%
In Situ Analysis
6%
Virus nucleic Acid
6%
R292K
6%
Nuclear factor-κB
6%
Antiviral Treatment
6%
Viral Shedding
6%
Desflurane
6%
H7N9
6%
Innate Immune Response
6%
Immunology and Microbiology
Hepatitis B Virus
100%
Hepatitis B
62%
Hepatitis B Antigen
27%
HBsAg
27%
Virus
20%
Interferon
19%
Viral Replication
19%
RNA Virus
16%
DNA Virus
15%
Infectious Agent
13%
Influenza A Virus (H7N9)
13%
COVID-19
13%
Capsid
13%
In Situ Hybridization
10%
Influenza
9%
Gene Expression
8%
Virion
8%
DNA RNA Hybridization
8%
Cell Culture
8%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Lineage
7%
Blood Plasma
7%
Mouse Model
7%
Fluorescence in Situ Hybridization
7%
Hepatitis C Virus
7%
Interferon Alfa
7%
Membrane Antigen
6%
Viral Shedding
6%
Hepatoma Cell
6%
Metagenomics
6%
Virus Antigen
6%
Promoter Region
5%
Secretion (Process)
5%
Viral Load
5%
Immune Response
5%
Viral Disease
5%
